Welcome to LookChem.com Sign In|Join Free

CAS

  • or
MONO-BENZYL MALONATE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

40204-26-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 40204-26-0 Structure
  • Basic information

    1. Product Name: MONO-BENZYL MALONATE
    2. Synonyms: MONO-BENZYL MALONATE;MALONIC ACID MONO-BENZYL ESTER;Propanedioic acid, Mono(phenylMethyl) ester;Mono-Benzyl Malonate 95%;3-(benzyloxy)-3-oxopropanoic acid
    3. CAS NO:40204-26-0
    4. Molecular Formula: C10H10O4
    5. Molecular Weight: 194.18
    6. EINECS: N/A
    7. Product Categories: C10 to C11;Carbonyl Compounds;Esters
    8. Mol File: 40204-26-0.mol
  • Chemical Properties

    1. Melting Point: 47-51 °C(lit.)
    2. Boiling Point: 352.3 °C at 760 mmHg
    3. Flash Point: 141.3 °C
    4. Appearance: White to off-white/Powder or Crystalline Powder
    5. Density: 1.266 g/cm3
    6. Vapor Pressure: 1.43E-05mmHg at 25°C
    7. Refractive Index: 1.543
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
    10. PKA: 2.82±0.32(Predicted)
    11. CAS DataBase Reference: MONO-BENZYL MALONATE(CAS DataBase Reference)
    12. NIST Chemistry Reference: MONO-BENZYL MALONATE(40204-26-0)
    13. EPA Substance Registry System: MONO-BENZYL MALONATE(40204-26-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 40204-26-0(Hazardous Substances Data)

40204-26-0 Usage

Uses

Monobenzyl Malonate is a useful synthetic intermediate. It was used to synthesize constrained cyclic agonists of the cholecystokinin CCK-B receptor. It was also used to prepare aspartate transcarbamoylase inhibitors.

Definition

ChEBI: A dicarboxylic acid monoester obtained by the formal condensation of one of the carboxy groups of malonic acid with benzyl alcohol.

General Description

mono-Benzyl malonate can be synthesized by the reaction of Meldrum′s acid (2,2-dimethyl- 1,3-dioxane-4,6-dione) with benzyl alcohol.

Check Digit Verification of cas no

The CAS Registry Mumber 40204-26-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,0 and 4 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 40204-26:
(7*4)+(6*0)+(5*2)+(4*0)+(3*4)+(2*2)+(1*6)=60
60 % 10 = 0
So 40204-26-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H10O4/c11-9(12)6-10(13)14-7-8-4-2-1-3-5-8/h1-5H,6-7H2,(H,11,12)

40204-26-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(benzyloxy)-3-oxopropanoic acid

1.2 Other means of identification

Product number -
Other names benzyloxycarbonyl-2-iodoethylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:40204-26-0 SDS

40204-26-0Relevant articles and documents

Rational Design and Synthesis of Methyl-β- d -galactomalonyl Phenyl Esters as Potent Galectin-8 N Antagonists

Patel, Brijesh,Kishor, Chandan,Houston, Todd. A.,Shatz-Azoulay, Hadas,Zick, Yehiel,Vinik, Yaron,Blanchard, Helen

supporting information, p. 11573 - 11584 (2020/12/02)

Galectin-8 is a β-galactoside-recognizing protein having an important role in the regulation of bone remodeling and cancer progression and metastasis. Methyl β-d-galactopyranoside malonyl aromatic esters have been designed to target and engage with particular amino acid residues of the galectin-8N extended carbohydrate-binding site. The chemically synthesized compounds had in vitro binding affinity toward galectin-8N in the range of 5-33 μM, as evaluated by isothermal titration calorimetry. This affinity directly correlated with the compounds' ability to inhibit galectin-8-induced expression of chemokines and proinflammatory cytokines in the SUM159 breast cancer cell line. X-ray crystallographic structure determination revealed that these monosaccharide-based compounds bind galectin-8N by engaging its unique arginine (Arg59) and simultaneously cross-linking to another arginine (Arg45) located across the carbohydrate-binding site. This structure-based drug design approach has led to the discovery of novel monosaccharide galactose-based antagonists, with the strongest-binding compound (Kd 5.72 μM) holding 7-fold tighter than the disaccharide lactose.

Design, Synthesis, and Activity Study of Water-Soluble, Rapid-Release Propofol Prodrugs

Liu, Liang-Quan,Hong, Pei-Xi,Song, Xing-Hai,Zhou, Chang-Cui,Ling, Rui,Kang, Yi,Qi, Qing-Rong,Yang, Jun

supporting information, p. 7857 - 7866 (2020/08/21)

In this work, a series of water-soluble propofol prodrugs were synthesized, and their propofol release rate and pharmacodynamic characteristics were measured. We found that inserting glycolic acid as a linker between propofol and the cyclic amino acid accelerated the release of propofol from prodrugs into the plasma while preserving its safety. In animal experiments, prodrugs (3e, 3g, and 3j) were significantly better than fospropofol (the only water-soluble propofol prodrug that has been used clinically) in terms of safety, onset, and duration time of anesthesia. Their molar dose, onset time, and anesthesia duration time were comparable to those of propofol, helping to maintain the clinical benefits of propofol. The experimental results showed the potential of such compounds as water-soluble prodrugs of propofol.

Design and synthesis of Coenzyme A analogues as Aurora kinase A inhibitors: An exploration of the roles of the pyrophosphate and pantetheine moieties

Bellany, Fiona,Tsuchiya, Yugo,Tran, Trang M.,Chan, A.W. Edith,Allan, Helen,Gout, Ivan,Tabor, Alethea B.

supporting information, (2020/09/16)

Coenzyme A (CoA) is a highly selective inhibitor of the mitotic regulatory enzyme Aurora A kinase, with a novel mode of action. Herein we report the design and synthesis of analogues of CoA as inhibitors of Aurora A kinase. We have designed and synthesised modified CoA structures as potential inhibitors, combining dicarbonyl mimics of the pyrophosphate group with a conserved adenosine headgroup and different length pantetheine-based tail groups. An analogue with a -SH group at the end of the pantotheinate tail showed the best IC50, probably due to the formation of a covalent bond with Aurora A kinase Cys290.

Synthesis and characterization of CAPE derivatives as xanthine oxidase inhibitors with radical scavenging properties

Choi, Wonbeen,Villegas, Valente,Istre, Hannah,Heppler, Ben,Gonzalez, Niki,Brusman, Nicole,Snider, Lindsey,Hogle, Emily,Tucker, Janelle,O?ate, Alma,O?ate, Sandra,Ma, Lili,Paula, Stefan

, p. 686 - 695 (2019/03/05)

Inhibitors of the enzyme xanthine oxidase (XO) with radical scavenging properties hold promise as novel agents against reperfusion injuries after ischemic events. By suppressing the formation of damaging reactive oxygen species (ROS) by XO or scavenging ROS from other sources, these compounds may prevent a buildup of ROS in the aftermath of a heart attack or stroke. To combine these two properties in a single molecule, we synthesized and characterized the non-purine XO inhibitor caffeic acid phenethylester (CAPE) and 19 derivatives using a convenient microwave-assisted Knoevenagel condensation protocol. Varying systematically the number and positions of the hydroxyl groups at the two phenyl rings, we derived structure-activity relationships based on experimentally determined XO inhibition data. Molecular docking suggested that critical enzyme/inhibitor interactions involved π-π interactions between the phenolic inhibitor ring and Tyr914, hydrogen bonds between inhibitor hydroxyl groups and Glu802, and hydrophobic interactions between the CAPE phenyl ring and non-polar residues located at the entrance of the binding site. To effectively scavenge the stable radical DPPH, two hydroxyl groups in 1,2- or 1,4-position at the phenyl ring were required. Among all compounds tested, E-phenyl 3-(3,4-dihydroxyphenyl)acrylate, a CAPE analog without the ethyl tether, showed the most promising properties.

Design, synthesis and biological screening of N-(substituted pyridine-2-yl)-N-(quinoline-2-yl) malonamide as novel anti-HIV-I agents

Kashid, Arun Maruti,Dhawale, Shasbikant

, p. 870 - 879 (2019/05/21)

A novel series of N1-(substiruted pyridine-2-yl)-N3-(quinoline-2-yl) malonamide derivatives (AK1-AK24) has been rationally designed, synthesized and biologically screened for in vitro anti HIV activity by using reverse transcriptase assay kit (Roche). Out of the synthesized compounds, compound AK1, AK2 and AK3 show potent reverse transcriptase (RT) inhibitor activity and compounds AK4 to AK9, AK11, AK12, AK13 and AK14 show RT inhibitory activity comparable with standard rilpivirine. In docking studies, those compounds show higher G-Score which indicates higher percentage of inhibition of reverse transcriptase during in vitro screening. Insilico pharmacokinetic studies imply that synthesized derivatives have no CYP450 inhibition, no BBB penetration and good oral absorption. Virtual toxicity studies performed by using Toxtree-v 2.6.6 in various computational animal models show high LD50 values and the compounds are found to be non-carcinogenic.

Development of catalytic deacylative alkylations (DaA) of 3-acyl-2-oxindoles: total synthesis of meso-chimonanthine and related alkaloids

Kumar, Nivesh,Das, Mrinal Kanti,Ghosh, Santanu,Bisai, Alakesh

supporting information, p. 2170 - 2173 (2017/02/19)

We present an effective deacylative alkylation strategy for the construction of a variety of 2-oxindoles bearing an all-carbon quaternary center at the pseudobenzylic position. A wide variety of products with quaternary centers could be accessed by employing simple Pd(0) catalysis under mild reaction conditions. Importantly, the same strategy works equally well for the dimeric 2-oxindole system, furnishing products with a vicinal quaternary center in favour of meso-isomer as the major product. Eventual application to the total syntheses of meso-chimonanthine and meso-folicanthine very well demonstrates the synthetic potential of this strategy.

Synthesis of 2-oxindoles via 'transition-metal-free' intramolecular dehydrogenative coupling (IDC) of sp2 C-H and sp3 C-H bonds

Kumar, Nivesh,Ghosh, Santanu,Bhunia, Subhajit,Bisai, Alakesh

supporting information, p. 1153 - 1169 (2016/07/06)

The synthesis of a variety of 2-oxindoles bearing an all-carbon quaternary center at the pseudo benzylic position has been achieved via a 'transition-metal-free' intramolecular dehydrogenative coupling (IDC). The construction of 2-oxindole moieties was carried out through formation of carbon-carbon bonds using KOt-Bu-catalyzed one pot C-alkylation of β-N-arylamido esters with alkyl halides followed by a dehydrogenative coupling. Experimental evidences indicated toward a radical-mediated path for this reaction.

Syntheses and evaluation of substituted aromatic hydroxamates and hydroxamic acids that target Mycobacterium tuberculosis

Majewski, Mark W.,Cho, Sanghyun,Miller, Patricia A.,Franzblau, Scott G.,Miller, Marvin J.

supporting information, p. 4933 - 4936 (2015/10/28)

Tuberculosis (TB) continues to remain one of the most threatening diseases in the world. With the emergence of multi-drug resistant (MDR) and extensively drug resistant (XDR) strains, the need to develop new therapies is dire. The syntheses of a focused library of hydroxamates and hydroxamic acids is described, as well as anti-TB activity in the microplate alamar blue assay (MABA). A number of compounds exhibited good activity against Mtb, with notable compounds exhibiting MIC values in the range of 20-0.71 μM. This work suggests that both hydroxamates and their free acids may be incorporated into more complex scaffolds and serve as potential leads for the development of anti-TB agents.

Synthesis and antitumor activity of feruloyl and caffeoyl derivatives This paper is dedicated to Prof. Wei-xiao Hu for his lifelong commitment to mentoring graduate students

Chen, Hui-Zhen,Chen, You-Bao,Lv, Ya-Ping,Zeng, Fang,Zhang, Juan,Zhou, Yong-Lie,Li, Han-Bing,Chen, Li-Fei,Zhou, Bin-Jie,Gao, Jian-Rong,Xia, Chun-Nian

supporting information, p. 4367 - 4371 (2015/02/06)

We developed two efficient protocols for the synthesis of feruloyl and caffeoyl derivatives from commercial vanillin and veratraldehyde. Pharmacological activities were assessed against a panel of human cancer cell lines in vitro. Most synthesized compounds demonstrated attractive cytotoxicity. Several new compounds demonstrated significant antiproliferative and cytotoxic activities against HeLa and Bewo tumor cell lines. In particular, 5-nitro caffeic adamantyl ester showed broad spectrum of tumor inhibition in 10 cell lines, and reduced tumor weight by 36.7% in vivo when administered at a dose of 40 mg kg-1.

DDQ-mediated direct Intramolecular-Dehydrogenative-Coupling (IDC): Expeditious approach to the tetracyclic core of ergot alkaloids

Bhunia, Subhajit,Ghosh, Santanu,Dey, Dhananjay,Bisai, Alakesh

supporting information, p. 2426 - 2429 (2013/06/27)

An efficient route to 2-oxindoles bearing an all-carbon quaternary center at the pseudobenzylic position has been developed via a DDQ-mediated Intramolecular-Dehydrogenative-Coupling (IDC). The methodology involves a one-pot C-alkylation of β-N-arylamido esters (7) concomitant with dehydrogenative-coupling in the presence of stoichiometric amount of DDQ. A tentative mechanistic route has been proposed for the oxidative coupling. The methodology provides a two-step entry to the ergoline structure of ergot alkaloids.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 40204-26-0